Innate Pharma S.A.
IPHA
$2.03
$0.021.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 70.50M | 64.88M | 83.62M | 90.08M | 98.36M |
| Total Receivables | 1.41M | 1.30M | 1.70M | 1.83M | 14.82M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.53M | 2.32M | 2.92M | 3.15M | 3.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.87M | 1.73M | 527.00K | 567.70K | 3.17M |
| Total Current Assets | 76.31M | 70.23M | 88.77M | 95.63M | 119.57M |
|
|
|||||
| Total Current Assets | 76.31M | 70.23M | 88.77M | 95.63M | 119.57M |
| Net Property, Plant & Equipment | 5.82M | 5.36M | 5.31M | 5.73M | 6.16M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 127.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.81M | 13.63M | 10.25M | 11.05M | 25.38M |
| Total Assets | 109.15M | 100.45M | 114.98M | 123.87M | 162.32M |
|
|
|||||
| Total Accounts Payable | 5.34M | 4.92M | 8.20M | 8.84M | 9.38M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.49M | 9.66M | 9.02M | 9.71M | 9.57M |
| Total Finance Division Other Current Liabilities | 18.72M | 17.23M | 16.93M | 18.24M | 22.01M |
| Total Other Current Liabilities | 18.72M | 17.23M | 16.93M | 18.24M | 22.01M |
| Total Current Liabilities | 34.56M | 31.81M | 34.15M | 36.79M | 40.96M |
|
|
|||||
| Total Current Liabilities | 34.56M | 31.81M | 34.15M | 36.79M | 40.96M |
| Long-Term Debt | 21.07M | 19.39M | 22.97M | 24.74M | 28.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 177.30K | 163.20K | 107.70K | 116.00K | 175.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 47.30M | 43.53M | 48.61M | 52.37M | 62.04M |
| Total Liabilities | 103.10M | 94.89M | 105.83M | 114.01M | 131.47M |
|
|
|||||
| Common Stock & APIC | 483.45M | 444.94M | 409.12M | 440.74M | 417.98M |
| Retained Earnings | -478.81M | -440.67M | -400.00M | -430.92M | -387.50M |
| Treasury Stock & Other | 1.40M | 1.29M | 28.00K | 30.10K | 380.40K |
| Total Common Equity | 6.04M | 5.56M | 9.15M | 9.85M | 30.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.04M | 5.56M | 9.15M | 9.85M | 30.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.04M | 5.56M | 9.15M | 9.85M | 30.85M |
|
|
|||||